rs35884952

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001378964.1(CDON):​c.1671G>A​(p.Lys557Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0224 in 1,614,058 control chromosomes in the GnomAD database, including 468 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 33 hom., cov: 32)
Exomes 𝑓: 0.023 ( 435 hom. )

Consequence

CDON
NM_001378964.1 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0280

Publications

3 publications found
Variant links:
Genes affected
CDON (HGNC:17104): (cell adhesion associated, oncogene regulated) This gene encodes a cell surface receptor that is a member of the immunoglobulin superfamily. The encoded protein contains three fibronectin type III domains and five immunoglobulin-like C2-type domains. This protein is a member of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells and positively regulates myogenesis. [provided by RefSeq, Aug 2011]
CDON Gene-Disease associations (from GenCC):
  • holoprosencephaly 11
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Illumina
  • pituitary stalk interruption syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.036).
BP6
Variant 11-126005939-C-T is Benign according to our data. Variant chr11-126005939-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.028 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.017 (2586/152212) while in subpopulation NFE AF = 0.0263 (1785/67996). AF 95% confidence interval is 0.0252. There are 33 homozygotes in GnomAd4. There are 1235 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2586 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDONNM_001378964.1 linkc.1671G>A p.Lys557Lys synonymous_variant Exon 9 of 20 ENST00000531738.6 NP_001365893.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDONENST00000531738.6 linkc.1671G>A p.Lys557Lys synonymous_variant Exon 9 of 20 1 NM_001378964.1 ENSP00000432901.2

Frequencies

GnomAD3 genomes
AF:
0.0170
AC:
2586
AN:
152094
Hom.:
33
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00406
Gnomad AMI
AF:
0.0319
Gnomad AMR
AF:
0.00995
Gnomad ASJ
AF:
0.0133
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00497
Gnomad FIN
AF:
0.0326
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0262
Gnomad OTH
AF:
0.0153
GnomAD2 exomes
AF:
0.0181
AC:
4544
AN:
251110
AF XY:
0.0182
show subpopulations
Gnomad AFR exome
AF:
0.00400
Gnomad AMR exome
AF:
0.00954
Gnomad ASJ exome
AF:
0.0156
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0315
Gnomad NFE exome
AF:
0.0266
Gnomad OTH exome
AF:
0.0157
GnomAD4 exome
AF:
0.0229
AC:
33517
AN:
1461846
Hom.:
435
Cov.:
32
AF XY:
0.0223
AC XY:
16231
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.00338
AC:
113
AN:
33480
American (AMR)
AF:
0.00937
AC:
419
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0168
AC:
439
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00636
AC:
549
AN:
86258
European-Finnish (FIN)
AF:
0.0322
AC:
1722
AN:
53420
Middle Eastern (MID)
AF:
0.00641
AC:
37
AN:
5768
European-Non Finnish (NFE)
AF:
0.0261
AC:
29037
AN:
1111970
Other (OTH)
AF:
0.0199
AC:
1201
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
1964
3928
5891
7855
9819
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1074
2148
3222
4296
5370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0170
AC:
2586
AN:
152212
Hom.:
33
Cov.:
32
AF XY:
0.0166
AC XY:
1235
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.00404
AC:
168
AN:
41542
American (AMR)
AF:
0.00994
AC:
152
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0133
AC:
46
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00498
AC:
24
AN:
4822
European-Finnish (FIN)
AF:
0.0326
AC:
346
AN:
10608
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0263
AC:
1785
AN:
67996
Other (OTH)
AF:
0.0152
AC:
32
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
122
244
367
489
611
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0236
Hom.:
67
Bravo
AF:
0.0151
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0234
EpiControl
AF:
0.0247

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 28, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Holoprosencephaly 11 Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
3.1
DANN
Benign
0.46
PhyloP100
0.028
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35884952; hg19: chr11-125875834; COSMIC: COSV54994958; COSMIC: COSV54994958; API